Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $95.9400 (0.28%) ($94.1800 - $96.5900) on Thu. Oct. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 23 | Latest Price | $95.9400(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.365% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-6%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
1 - 5 Day Possible Target | $86.38(-9.96%) | Resistance Level | $105.01 | 5 Day Moving Average | $97.77(-1.87%) | 10 Day Moving Average | $99.19(-3.28%) | 20 Day Moving Average | $105.01(-8.64%) | To recent high | -30.7% | To recent low | 0.3% | Market Cap | $1.542b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |